Key Findings

The study reports the first identification of extensively drug-resistant Mycobacterium tuberculosis clinical isolates with resistance to bedaquiline, linezolid, and clofazimine in Uganda, highlighting the importance of adherence to treatment and the need for improved surveillance and diagnostics.